Lakefront Biotherapeutics (LKFT) EBITDA Margin Growth (3y) (2017 - 2026)
Lakefront Biotherapeutics (LKFT) EBITDA Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -40,178.00 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 530.00 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn | -95,868.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -95,868.00 |
| Dec 31, 2025 | 8,642.00 |
| Sep 30, 2025 | -61,971.00 |
| Mar 31, 2025 | -19,617.00 |
| Dec 31, 2024 | 19,508.00 |
| Jun 30, 2024 | -37,021.00 |
| Mar 31, 2024 | -847.00 |
| Dec 31, 2023 | 7,364.00 |
| Sep 30, 2023 | 2,886.00 |
| Jun 30, 2023 | 6,605.00 |
| Mar 31, 2023 | 2,036.00 |
| Dec 31, 2022 | 37.00 |
| Sep 30, 2022 | -9,278.00 |
| Mar 31, 2022 | 14,560.00 |
| Dec 31, 2021 | -1,009.00 |
| Jun 30, 2021 | 3,449.00 |
| Mar 31, 2021 | 3,991.00 |
| Dec 31, 2020 | 637.00 |
| Sep 30, 2020 | 5,795.00 |
| Jun 30, 2020 | -806.00 |